ANDA 204731, held by Akorn Inc. Palonosetron Hydrochloride.
As of Nov 16, 2026, ANDA 204731 (Palonosetron Hydrochloride), held by Akorn Inc, was not approved, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 9, 2015 | Original application | Tentative approval | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Palonosetron Hydrochloride0.25MG(BASE)/5ML ยท injectable;injection | Palonosetron Hydrochloride | None (tentative approval) |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters